Abstract
Purpose :
To develop a self-supervised model based on deep learning (DL) and contrastive learning (CL) for segmentation of diabetic macular edema (DME)-induced lesions based on OCT scans.
Methods :
We developed a self-supervised DL-CL model with two stages of training (Fig 1) based on 13,000 OCT scans collected from the publicly available Zang dataset (dataset 1) and 610 OCT scans collected from the publicly available Duke-II dataset (dataset 2). In the first stage, we developed an encoder-decoder model based on RAG-NET architecture and employed a cross entropy loss function (Lic) then trained the model based on annotated OCT scans with manifestations of intra-retinal fluid (IRF), sub-retinal fluid (SRF), and hard exudates (HE) lesions (from the first dataset). In the second stage, we developed a CL model and employed a contrastive loss function (Lc), to learn retinal lesion segmentation in a self-supervised manner based on unlabeled OCT scans (from the second dataset). This is achieved by imposing self-supervised constraining on the segmentation using contrastive loss function. We trained our model based on a subset of OCT scans from both datasets and validated the model based on an independent subset from dataset 1 with 3000 OCT scans (Fig 2).
Results :
The area under the receiver operating characteristics curves (AUCs) of the model in detecting DME lesion for labeled and unlabeled data were 0.96 and 0.94 respectively.
Conclusions :
We developed a self-supervised contrastive learning-driven model that segments DME lesions without any labels. The proposed model may help clinicals for diagnosing DME.
This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.